Gene Query: SCLT1

Dataset Description Geneva Score
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 22.84
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 22.4
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 20.56
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 18.43
RNA sequencing of primary human platelets and in vitro cell lines 13.83
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 11.88
Oncogenic MYC induces a dependency on the spliceosome in human cancer 10.55
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 10.24
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 10.21
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 10.11
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 10.04
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 9.38
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 9.3
LncRNA expression profiling of ischemic stroke patients 8.48
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 7.83
RNA sequencing of matched nephrectomy samples [RNA-seq] 7.83
RNAseq Study in CC-671 Treated Cal-51 Cells 7.75
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 7.5
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 7.27
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 7.12
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 7.07
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 7.07
circRNA profile in hypopharyngeal cancer 6.8
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 6.75
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 6.52
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 6.39
Short and Long RNA sequencing of human mature erythrocytes 6.27
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 6.14
Intron retention induced by microsatellite expansions as a disease biomarker. 5.98
ARID1A regulates condensin II distribution and chromosomal partition 5.86
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 5.86
Expression profiling of etoposide-induced senescent cells 5.75
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 5.55
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 5.53
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 5.5
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 5.46
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 5.43
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 5.38
The evolution of N6-methyladenosine in primates 5.14
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 5.11
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 5.04
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 4.97
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 4.94
Transcriptome analysis of H9 hESC derived cerebral organoids 4.87
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 4.81
MicroRNA-125a-5p overexpression in human macrophages 4.76
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 4.75
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 4.74
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 4.73
Genome-wide discovery of human splicing branchpoints 4.64
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 4.53
Identification of renal resident macrophages across species 4.52
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 4.47
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 4.43
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 4.43
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 4.4
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 4.31
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 4.28
Human cell line and subcutaneous tumor 4.28
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 4.27
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 4.27
Widespread regulated alternative splicing of single codons accelerates proteome evolution 4.27
U2AF1 mutations alter splice site recognition in hematological malignancies 4.26
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 4.2
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 4.2
Mutational landscape of splicing genes and functional consequences across 33 cancer types 4.15
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 4.15
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 4.13
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 4.13
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 4.07
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 4.01
mRNA expression profile of Lymphocytes 3.98
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 3.98
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 3.96
Recovery and analysis of nascent RNA 3.96
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 3.92
Total RNA-seq in ALL-SIL upon JQ1 inhibition 3.78
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 3.76
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 3.76
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 3.73
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 3.7
Transcriptome of diurnal human blood neutrophils 3.68
Aging-associated patterns in the expression of human endogenous retroviruses 3.67
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 3.67
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 3.67
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 3.66
Effect of BMP inhibition or stimulation of primary human keratinocytes 3.65
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 3.65
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 3.56
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 3.5
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 3.47
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 3.47
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 3.45
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 3.43
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 3.42
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 3.41
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 3.41
Global Mapping of Human RNA-RNA Interactions 3.38
Transcriptomic profiling of human peripheral blood-derived mast cells 3.32
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 3.32
Dysregulated immune system networks in war veterans with PTSD 3.32
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 3.3
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 3.3
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 3.3
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 3.3
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 3.26
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 3.26
Identification of renal resident macrophages across species [C1] 3.24
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 3.21
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 3.19
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 3.17
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 3.16
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 3.11
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 3.07
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 3.07
Tpl-2 and MEK small molecule inhibitors 3.05
Tpl-2 small molecule project 3.05
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 3.03
single cell RNA-seq from GM12878 (ENCSR673UIY) 3.02
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 2.91
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 2.9
Regulation of poly(A) tail and translation during the somatic cell cycle 2.89
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 2.87
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 2.87
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 2.87
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 2.84
TGF-β regulation of miRNA expression in pancreatic cancer 2.83
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  2.83
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 2.81
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 2.8
Discovering human diabetes-risk gene function with genetics and physiological assays 2.8
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 2.79
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 2.74
MYCL and EP400 are required for Max and MCPyV mediated gene activation 2.69
Identification of Atrial Fibrillation associated genes and functional non-coding variants 2.69
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 2.65
CROP-Seq in Primary Human T Cells 2.64
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 2.64
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 2.64
Targeted enhancer activation by a subunit of the integrator complex 2.61
Transcriptome Profiling of Human Primary Monocytes 2.6
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 2.6
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 2.56
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 2.56
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 2.55
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 2.54
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 2.54
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 2.51
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 2.5
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 2.49
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 2.46
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 2.46
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 2.46
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 2.45
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 2.45
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 2.45
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 2.45
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 2.45
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 2.44
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 2.44
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 2.44
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 2.44
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 2.36
An optimization system for isolating and sequencing of single human colon cancer cells 2.35
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 2.35
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 2.35
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 2.35
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 2.35
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 2.34
Polarized B -cell functions 2.32
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 2.31
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 2.31
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 2.28
Peptidomimetic blockade of MYB in acute myeloid leukemia 2.27
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 2.27
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 2.26
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 2.26
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 2.26
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 2.25
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 2.25
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 2.25
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 2.25
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 2.25
CircRNAome diversity in human mature B-cells, T-cells and monocytes 2.24
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 2.22
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 2.22
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 2.19
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 2.17
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 2.15
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 2.15
Gene expression profile in breast cancer cells 2.15
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 2.15
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 2.14
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 2.14
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 2.13
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 2.12
Ribosomal footprinting of MDA-Parental and MDA-LM2 2.12
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 2.11
Human neutrophil genome during PMA- and E. coli encounter-induced activation 2.11
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 2.1
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 2.1
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 2.09
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 2.09
Ribosomal footprinting of CN34-Parental and CN34-LM1a 2.08
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 2.08
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 2.08
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 2.08
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 2.08
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 2.08
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 2.07
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 2.07
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 2.06
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 2.06
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 2.06
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 2.05
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 2.05
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 2.05
scRNASeq analysis of cycling cardiomyocytes 2.04
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 2.02
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 2.02
The Human Testis Cell Atlas via Single-cell RNA-seq 1.99
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 1.99
RNA-sequencing of formalin fixed human primary melanoma tissue 1.98
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 1.97
Integrating single-cell transcriptomic data across different conditions, technologies, and species 1.97
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 1.95
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 1.95
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 1.95
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 1.94
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 1.94
Transcriptomes of human monocytes after ex vivo exposure to uric acid 1.94
Landscape of H3K4me3 in human CD19 cells 1.93
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 1.92
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 1.92
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 1.91
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 1.9
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 1.89
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 1.89
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 1.89
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 1.89
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 1.89
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 1.89
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 1.89
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 1.87
RNA-seq of Single-Cell Genotyping of Transcriptomes 1.87
Single-Cell Genotyping of Transcriptomes 1.87
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 1.87
Generating Patterned Kidney Organoids for Studying Development and Diseases 1.86
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 1.85
Macrophage Ad5f35 M2 Challenge 1.83
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 1.78
Differential gene expression profiles in imatinib-resistant cell lines 1.78
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 1.77
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 1.76
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 1.76
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 1.74
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 1.74
Expression and functions of long noncoding RNAs during human T helper cell differentiation 1.74
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 1.73
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 1.7
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 1.69
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 1.69
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 1.69
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 1.63
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 1.62
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 1.6
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 1.55
RNA-Seq from human ILC transitional populations 1.55
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 1.54
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 1.52
Global transcriptome analysis of HAP1 cells 1.52
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 1.51
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 1.5
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 1.5
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 1.49
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 1.48
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 1.48
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 1.47
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 1.43
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 1.41
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 1.41
Capturing the Interactome of Newly Transcribed RNA 1.4
Capturing the Interactome of Newly Transcribed RNA (RICK) 1.4
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.4
Transcriptional landscape changes during human embryonic stem cell derivation 1.39
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 1.38
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 1.36
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 1.35
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 1.34
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 1.33
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 1.32
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 1.3
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 1.3
RNA-Seq in neutrophils from Antiphospholipid Syndrome 1.29
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 1.29
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 1.26
A code of mono-phosphorylation modulates the function of RB. 1.25
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 1.24
RNA sequencing with KSHV infection and enrichment for circular RNAs 1.23
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 1.23
RNA sequencing analysis of selumetinib-resistant CRC cells lines 1.2
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 1.18
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 1.17
Transcriptional profile in human S. haematobium infection 1.17
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 1.17
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.16
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 1.16
Hypoxic transcriptome of SQ20B human head and neck cancer cells 1.16
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 1.14
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 1.14
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 1.13
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 1.13
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.11
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 1.1
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 1.1
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 1.1
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 1.09
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 1.09
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 1.09
Microprocessor mediates transcription termination in long noncoding microRNA genes 1.09
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 1.09
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 1.09
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 1.08
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 1.07
Primate transcript and protein expression levels evolve under compensatory selection pressures 1.06
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 1.06
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 1.06
TOP2B disturbed the quality of human oocytes with advanced maternal age 1.05
Gene expression changes due to PARP knockdown in human cells 1.05
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 1.05
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 1.05
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 1.03
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 1.03
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 1.03
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 1.03
RNA-Seq of the corpus callosum from 12 individuals 1.0
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 0.99
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 0.99
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 0.98
Activity-dependent transcriptional changes in human neurons 0.97
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 0.96
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 0.96
Common inflammatory pathways between NEC and Crohn's disease 0.94
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.94
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.93
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 0.93
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 0.93
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 0.92
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.9
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 0.9
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 0.9
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 0.88
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 0.88
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 0.88
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.88
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.88
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 0.87
An integrative analysis of non-coding regulatory DNA variations associated with autism 0.87
Genome-wide identification of cancer-specific alternative splicing in circRNA 0.87
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 0.83
Transcriptional profiling of LS1034 cells treated with tepoxalin 0.82
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 0.8
RNA-seq analysis of differentiating human erythroblasts 0.8
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 0.79
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 0.79
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 0.75
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 0.75
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 0.75
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 0.75
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 0.74
6mer seed toxicity in tumour suppressive microRNAs 0.73
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 0.72
Characterization of human ILC2 subsets 0.72
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 0.71
RNA seq comparison between scrambled and shGRP78 cells 0.71
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 0.71
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.7
RNA-seq analysis of control and Myc-induced U2OS cells 0.7
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.69
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.69
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 0.69
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 0.68
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 0.67
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 0.67
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 0.66
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 0.64
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 0.63
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 0.63
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 0.62
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 0.61
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 0.61
Transcriptome-wide response to synthetic chromatin protein PcTF 0.61
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.59
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.59
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 0.58
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 0.58
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 0.58
Reprogrammed myeloid cell transcriptomes in NSCLC 0.57
siRNA-mediated knockdown 0.55
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 0.53
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 0.53
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.52
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 0.5
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.5
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 0.5
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 0.5
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 0.49
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.49
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 0.48
Determination of tRNA aminoacylation levels by high throughput sequencing 0.47
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 0.47
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 0.47
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.46
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 0.46
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.45
Oncogenic roles of ARID5B in T-ALL 0.45
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.44
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 0.44
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 0.44
The bromodomain protein BRD4 regulates splicing during heat shock 0.44
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.42
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.42
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.41
4sU-seq of HFF exposed to salt and heat stress 0.38
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.38
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 0.37
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 0.36
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 0.36
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.35
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 0.34
The cohesin complex prevents Myc-induced replication stress 0.33
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 0.32
SNHG5 siRNA knock down in HCT116 cells 0.32
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 0.31
Transcriptome analysis of peripheral blood monocytes 0.31
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 0.3
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.3
Genome-wide analysis of the Integrator complex 0.3
Genome-wide analysis of the Integrator complex (HTS) 0.3
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 0.3
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 0.29
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 0.28
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 0.28
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 0.27
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 0.26
hNSCs siRNA NOVA2 0.25
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 0.25
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.22
RNA-seq of primary patient AML samples 0.22
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.22
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.22
RNA-seq of MDA-MB-231 cells with TET1 knockout 0.21
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.2
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.2
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 0.19
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.19
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 0.19
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.19
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 0.17
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.17
Total RNA-Seq data from leukemic patients with complex structural variants 0.17
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 0.16
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.16
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 0.16
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.15
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.15
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 0.15
Gene expression signatures of innate lymphoid cells from human blood 0.15
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.13
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.13
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 0.12
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 0.11
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 0.11
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 0.1
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 0.09
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.08
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.08
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.08
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 0.08
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.08
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.08
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.08
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.08
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 0.08
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 0.08
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 0.06
Expression analysis of the TAF1 syndrome 0.05
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 0.05
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.04
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.04
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.03
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.03
Role of cervicovaginal microbiota in genital inflammation 0.03
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 0.02
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 0.02
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.02
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.01
LIN28A Over-expression RNAseq 0.0
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.0
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation